3Lukas J,Aagaard L,Stravss M. Oncogenic aberration of P16 and CyclinD1 cooperate to deregwlate G1 contyol [J]. Cancer Res, 1995,55: 4818～4823.
4Hichman KA,Roberts JM. Rules to Replicat by[J].Cell, 1994,79: 557～562.
5Hunter T,Pines J. Cyclins and Cancer Ⅱ :cyclinD and CDK inhibitors come of age [J]. Cell, 1994, 79:573～582.
6Xiong Y,Stage S,Takeda T et al. Telomerase activity in malignant tumours with dergulation of cell cycle regulator proteins [J]. Genomics, 1992,13: 575.
7Toshiya I,Shigemasa K,West CM et al. P16 overexpression. apotential early indicator of transformation in carcinoma[J]. Genomics, 1992,13: 565.
8Motokura T,Arnold A,Kim YT et al. Underexpression of cyclin dependent kinase (CDK) inhibitors in carcinoma[J]. Biochim Biophys Acta, 1993, 115 (1):63.
9Mannel S, Schuyer M. Sporadic CDKN2 (MTS1/P16INK4 ) gene alteration in humors [J]. Nature,1993,366: 704～707.
10Fujita M. Alteration of P16 and P15 genes in commen epithelial ovarian tumours[J]. Int J Cancer, 1997,74:148～155.
